Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Finalizes Device Symbol-In-Labeling Rule Retaining Glossary Requirement

This article was originally published in The Gray Sheet

Executive Summary

Industry complaints that a 2013 FDA proposal calling for a glossary explanation for standalone symbols used in device labels went beyond internationally harmonized standards did not persuade the agency to drop the glossary from its June 14 final rule, but FDA does provide more flexibility on symbols that can be employed in device labeling.

You may also be interested in...



Comments Open On Symbols In Device Labeling

US FDA is reopening the comment period on a rule that allows medical device manufacturers to use standardized symbols on product labeling. The docket will be open through May 20.

FDA’s Device Labeling Proposed Rule Misses The Mark, Industry Says

While device firms say FDA’s proposed rule on symbols in device labeling is needed, they say additional requirements for explanations of symbols in an accompanying glossary are duplicative.

Vemedia Acquires GSK Brands In Italy, Strikes Deal For GI Product In Spain

GSK has offloaded a further two brands, this time in Italy, giving Netherlands-based Vemedia the opportunity to bolster its portfolio in the country. Vemedia has also added to its offering in Spain by striking a separate deal with Puerto Galiano.

Topics

UsernamePublicRestriction

Register

MT034862

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel